CSL300_2301_Ph3

Medical

Free

CSL Behring eCOA App is intended for use to collect patient reported outcomes relating to the CSL300_2301 Phase 3 Clinical Trial The CSL Behring CSL300_2301 Phase 3 App is intended for use to collect patient reported outcomes relating to the CSL300_2301 Phase 3 clinical trial. Patients must be given accounts by a participating site in order to log in to the app

  • This app hasn’t received enough ratings or reviews to display an overview.

Release of Chinese_HK Language

The developer, ERT,INC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Not Linked to You

    The following data may be collected but it is not linked to your identity:

    • Health & Fitness

Privacy practices may vary, for example, based on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

Seller
  • ERT, INC
Size
  • 89.6 MB
Category
  • Medical
Compatibility
Requires iOS 12.0 or later.
  • iPhone
    Requires iOS 12.0 or later.
  • iPad
    Requires iPadOS 12.0 or later.
  • iPod touch
    Requires iOS 12.0 or later.
  • Apple Vision
    Requires visionOS 1.0 or later.
Languages
  • English
Age Rating
13+
  • 13+
  • Infrequent
    Medical Treatment information

    Contains
    Health or Wellness Topics
Copyright
  • © 2023 Clario, CSL Behring